Work

201 A Recombinant Native Human Anti-Tetanus Monoclonal Antibody Versus Human Tetanus Immunoglobulin for Passive Immunization Against Tetanus: A Double-Blind, Randomized, Phase 3 Trial

Year: 2024

Type: article

Study design: Clinical Trial

Source: Annals of Emergency Medicine

DOI: 10.1016/j.annemergmed.2024.08.206

Authors: X. Liu, C. Wang, Z. Liang, S. Liu, W. Guo, X. Liu, J. Ding, M. Zhang, X. Kuang, H. Liao, W. Wang

Language: English

Topic: Diphtheria, Corynebacterium, and Tetanus

Subfield: Endocrinology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4402757649

FWCI: 0.298

Cites:

Cited by: 1

Related to: 10